Unlock regulatory insights with Watson. Learn More
Return to Docket

Make a Determination Regarding ANDA Suitability for Carbamazepine Oral Suspension USP,200 mg/mL Based on the reference -listed drug , Tegretol Oral Suspension, 100 mg/mL of Novartis Pharmaceuitcals Corporation-CLOSED

Type: Non-Rule Making
KeyWord(s) Tara Pharmaceuitcals, tegretol, oral suspension, carbamazepine, ANDA, CDER, closed
Short title ANDA suitability for Carbamazepine Oral Suspension USP,200 mg/mL based on the reference-listed drug
Docket Item Code P
Center CDER

0 Comments

Click here to view all comments of this document.